Vanta Bioscience Limited reported earnings results for the half year ended September 30, 2023. For the half year, the company reported sales was INR 61.76 million compared to INR 28.24 million a year ago. Revenue was INR 62.06 million compared to INR 28.34 million a year ago.

Net loss was INR 5.36 million compared to INR 25.61 million a year ago. Basic loss per share from continuing operations was INR 0.85 compared to INR 4.06 a year ago. Diluted loss per share from continuing operations was INR 0.85 compared to INR 4.06 a year ago.